Mayne Pharma | MYX - Ebit

Stock Price
2.32
Daily Change
0.01 0.43%
Monthly
-7.57%
Yearly
-49.01%
Q2 Forecast
2.27

Mayne Pharma reported AUD-16.2M in EBIT for its fiscal semester ending in June of 2024.





Ebit Change Date
Ansell USD 146.5M 29.2M Dec/2025
Avita Medical AUD -10.39M 1.72M Dec/2025
Cochlear AUD 261.1M 13.9M Dec/2025
CSL USD 2.64B 116M Dec/2025
Healius AUD 23.7M 26M Dec/2024
Integral Diagnostics AUD 24.99M 5.08M Jun/2024
Medical Developments International AUD -36K 12.96M Dec/2025
Nanosonics AUD 9.12M 422K Dec/2025
Polynovo AUD 2.06M 1.18M Dec/2025
Ramsay Health Care AUD 541.1M 20.7M Dec/2025
ResMed USD 497.6M 35.25M Dec/2025
Sigma Healthcare AUD 809K 13.76M Dec/2024
Sonic Healthcare AUD 423.94M 80.3M Dec/2024
Telix Pharmaceuticals AUD 8.04M 3.21M Dec/2025